Pall Corp. to Acquire ForteBio

The transaction is expected to close by February of 2012. ForteBio will become a wholly-owned subsidiary of Pall Corp.

Pall Corp. has agreed to acquire analytical systems provider ForteBio, Inc.. The transaction is expected to close by February of 2012. ForteBio will become a wholly-owned subsidiary of Pall Corp.

ForteBio has a portfolio of innovative, label-free protein analysis instruments that will extend Pall’s capabilities in the $1 billion-plus biopharma process monitoring market and in the protein research market.

The analytical systems, which allow researchers to measure proteins in real time without the aid of fluorescent, radio or calorimetric labels or markers, will form a complement to Pall’s existing microbiological monitoring platforms.

"Pall’s strong global sales channel will extend the reach of ForteBio instruments